NDC 70121-1755-01
Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Generation details were not recorded for this description.
Original text from hospital filings
Bevacizumab-maly (Alymsys) 667.5 mg in sodium chloride 0.9 % 100 mL chemo infusion
Alexandria, LA
See all hospitals reporting NDC 70121-1755-01 →Price type
St. Frances Cabrini Hospital’s median price of $14.7k is 304% above the median hospital's median price ($3.6k), higher than 96% of the 178 hospitals reporting NDC 70121-1755-01. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Last updated: Jan 13, 2026
See BEVACIZUMAB-MALY 25 MG/ML INTRAVENOUS SOLUTION pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.